65
https://pubmed.ncbi.nlm.nih.gov/38093391
The study has identified JAK2 as a surface marker for enriching human pluripotent stem cell-derived ventricular cardiomyocytes, exhibiting ventricular-like electrophysiological properties and reduced response to atrial-selective anti-arrhythmic agent.
